Add BrightSurf on Google Email

New insights into oral cancer without traditional risk factors

Researchers identified four distinct mutational clusters in oral cancers lacking traditional risk factors, with two linked to endogenous processes and unique driver gene mutations. The study suggests a potential role of the oral microbiome in tumor development and highlights opportunities for precision medicine approaches.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalInternational Journal of Oral Science·TypeData/statistical analysis·DateMay 22, 2026

Study sheds light on how early pancreas lesions become cancerous

Researchers have discovered that precursor lesions in the pancreas, often considered a step towards cancer, do not undergo malignant transformation if they lack a specific microenvironment. The team used advanced technologies to isolate and analyze single cells from over 150 donated pancreases, finding that the microenvironment surroun...

SourceMichigan Medicine - University of Michigan·JournalCancer Discovery·TypeExperimental study·DateMay 21, 2026

Garvan scientists capture ‘housekeeping’ immune cells attacking live melanoma

Scientists at the Garvan Institute of Medical Research captured 'housekeeping' immune cells actively attacking and engulfing live melanoma cells. These macrophages patrol the edges of melanoma tumours, steadily engulfing cancer cells and slowing tumour growth. The discovery has big implications for immunotherapy.

SourceGarvan Institute of Medical Research·JournalJournal of Experimental Medicine·TypeExperimental study·DateMay 21, 2026

Shining light on cell-to-cell communication

A new nanoscopy technique developed at ANU has uncovered hidden networks used for communication between cells. The breakthrough allows researchers to observe how living cells interact with their environment over several days, revealing three-dimensional behaviours that were previously invisible to conventional microscopes.

SourceAustralian National University·TypeExperimental study·DateMay 14, 2026

How a cell doubles its DNA matters more than we thought

Researchers examined two mechanisms of whole genome duplication in cells, finding that cytokinesis failure leads to more stable and viable cells, while mitotic slippage results in uneven chromosome distribution and reduced viability. The study suggests targeting chromosome separation could help limit survival of abnormal cells.

SourceHokkaido University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 30, 2026

A CNIO group contributes to identifying which breast lesions will progress to cancer, thus helping avoid overtreatment

A study by the CNIO group has identified a genetic signature in precancerous breast lesions that can predict which ones will evolve into invasive tumours. This discovery could help avoid over-treatment of women diagnosed with ductal carcinoma in situ, a common precancerous lesion.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalNature Communications·TypeExperimental study·DateApr 20, 2026

A redesigned endoscope offers a new way to look for early signs of ovarian cancer

A redesigned endoscope, called CAFE, offers a new way to detect early signs of ovarian cancer by combining high-resolution imaging with gentle cell collection. The device successfully imaged fallopian tube tissue and collected large numbers of epithelial cells, suggesting its potential for earlier disease detection.

SourceSPIE--International Society for Optics and Photonics·JournalBiophotonics Discovery·DateApr 2, 2026

An avatar to study pediatric brain cancer

A team of researchers has created a 3D model of pediatric brain tumors using biopsy-derived organoids, allowing for more accurate testing of new drugs. The model, which accurately reproduces the human environment, preserves the molecular characteristics of the original tumor and maintains cellular heterogeneity.

SourceUniversità di Trento·JournalNature Protocols·TypeExperimental study·DateMar 30, 2026

The cost of survival: Women more likely to survive cancer but suffer more severe side effects

A recent study found that women have a 21% lower risk of death compared to men, but a 12% higher risk of severe side effects from cancer treatment. The research, conducted in partnership with international collaborators, analyzed data from over 20,000 cancer patients and identified sex-based differences in survival and treatment toxicity.

SourceAdelaide University·JournalJNCI Journal of the National Cancer Institute·TypeMeta-analysis·DateMar 15, 2026

Overcoming ovarian cancer’s resistance to immunotherapy

A new study demonstrates that blocking a signaling protein called FAK helps mobilize an anti-tumor immune response, allowing tumor-fighting cells to approach tumors and shift the behavior of other immune cells to work against them. This approach achieved the best effects on immune cell recruitment, tumor size reduction, and survival ti...

SourceSanford Burnham Prebys·JournalCell Reports·TypeExperimental study·DateMar 5, 2026

New study suggests a “kick it while it’s down” approach to cancer treatment could improve cure rates

A new study suggests that switching to a second treatment while a tumor is still responding to the first may improve cure rates. The 'kick it while it's down' approach targets small tumors and has been shown to be successful in other contexts, such as combatting antibiotic resistance.

SourceCity St George’s, University of London·JournalGenetics·TypeComputational simulation/modeling·DateFeb 20, 2026

Seeing thyroid cancer in a new light: when AI meets label-free imaging in the operating room

Researchers combined Dynamic Optical Contrast Imaging (DOCI) with machine learning to identify thyroid cancer during surgery. The AI analysis framework accurately classified samples across three categories and generated tumor probability maps for precise location identification.

SourceSPIE--International Society for Optics and Photonics·JournalBiophotonics Discovery·TypeObservational study·DateJan 6, 2026

Subtyping colorectal cancer

Researchers at Kyoto University identified five molecular subtypes of colorectal cancer stem cells and developed a practical prognostic indicator, the general colorectal cancer signature (GCS), to predict patient outcomes. The GCS was validated with a novel orthotopic xenograft mouse model and showed promising clinical significance.

SourceKyoto University·JournalCancer Science·TypeObservational study·DateDec 18, 2025